These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31862175)

  • 21. Long-term effects and complications of the transjugular intrahepatic portosystemic shunt: a single-centre experience.
    Kraglund F; Jepsen P; Amanavicius N; Aagaard NK
    Scand J Gastroenterol; 2019 Jul; 54(7):899-904. PubMed ID: 31203699
    [No Abstract]   [Full Text] [Related]  

  • 22. Transjugular intrahepatic portosystemic shunts: an update.
    Rosado B; Kamath PS
    Liver Transpl; 2003 Mar; 9(3):207-17. PubMed ID: 12619016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary aquaporin-2 excretion before and after transjugular intrahepatic portosystemic shunt insertion for refractory ascites.
    Geilswijk M; Thomsen KL; Pedersen EB; Vilstrup H; Grønbæk H
    Scand J Gastroenterol; 2015 Apr; 50(4):454-61. PubMed ID: 25637473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transjugular intrahepatic portosystemic shunts (TIPS).
    Kamath PS; McKusick MA
    Baillieres Clin Gastroenterol; 1997 Jun; 11(2):327-49. PubMed ID: 9395751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of TIPS in patients with Refractory Ascites and Portal Vein Thrombosis.
    Chinchilla-López P; Hamdan-Pérez N; Guerrero-Ixtlahuac J; Barranco-Fragoso B; Méndez-Sánchez N
    Ann Hepatol; 2017; 16(4):619-620. PubMed ID: 28611269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incrementally Expandable Transjugular Intrahepatic Portosystemic Shunts: Single-Center Experience.
    Cui J; Smolinski SE; Liu F; Xu D; Dulaimy K; Irani Z
    AJR Am J Roentgenol; 2018 Feb; 210(2):438-446. PubMed ID: 29261352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Transjugular intrahepatic portosystemic stent shunt: indications and long-term outcome].
    Wettstein M; Lüthen R; Cohnen M; von Wrisberg F; Mödder U; Häussinger D
    Zentralbl Chir; 2005 Jun; 130(3):246-9. PubMed ID: 15965878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The transjugular intrahepatic portosystemic shunt: an update.
    Fidelman N; Kwan SW; LaBerge JM; Gordon RL; Ring EJ; Kerlan RK
    AJR Am J Roentgenol; 2012 Oct; 199(4):746-55. PubMed ID: 22997364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of complications of portal hypertension in patients with liver cirrhosis].
    Grønbaek H; Astrup LB; Nielsen DT; Vilstrup H
    Ugeskr Laeger; 2003 Jan; 165(5):439-42. PubMed ID: 12599838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.
    Berres ML; Asmacher S; Lehmann J; Jansen C; Görtzen J; Klein S; Meyer C; Strunk HM; Fimmers R; Tacke F; Strassburg CP; Trautwein C; Sauerbruch T; Wasmuth HE; Trebicka J
    J Hepatol; 2015 Feb; 62(2):332-9. PubMed ID: 25457205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transjugular intrahepatic portosystemic shunts in liver transplant recipients.
    Bonnel AR; Bunchorntavakul C; Rajender Reddy K
    Liver Transpl; 2014 Feb; 20(2):130-9. PubMed ID: 24142390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites.
    Bureau C; Thabut D; Oberti F; Dharancy S; Carbonell N; Bouvier A; Mathurin P; Otal P; Cabarrou P; Péron JM; Vinel JP
    Gastroenterology; 2017 Jan; 152(1):157-163. PubMed ID: 27663604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility and efficacy of transjugular intrahepatic portosystemic shunt (TIPS) in children.
    Di Giorgio A; Agazzi R; Alberti D; Colledan M; D'Antiga L
    J Pediatr Gastroenterol Nutr; 2012 May; 54(5):594-600. PubMed ID: 22228077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between portal/hepatic vein gradient and response to transjugular intrahepatic portosystemic shunt creation in refractory ascites.
    Nair S; Singh R; Yoselewitz M
    J Vasc Interv Radiol; 2004 Dec; 15(12):1431-4. PubMed ID: 15590801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transjugular intrahepatic portosystemic shunt: efficacy for the treatment of portal hypertension and impact on liver transplantation.
    Cosenza CA; Hoffman AL; Friedman ML; Sher LS; Lopez RR; Van Allen R; Brown DH; Fraiman MH; Arnaout W; Vierling J; Makowka L
    Am Surg; 1996 Oct; 62(10):835-9. PubMed ID: 8813166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transjugular intrahepatic portosystemic shunt--role in treating intractable variceal bleeding, ascites, and hepatic hydrothorax.
    LaBerge JM
    Clin Liver Dis; 2006 Aug; 10(3):583-98, ix. PubMed ID: 17162229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics and outcomes of transjugular intrahepatic portosystemic shunt recipients in the VA Healthcare System.
    Lerrigo R; Beste LA; Leipertz SL; Green PK; Lok AS; Kogut MJ; Ioannou GN
    Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):667-75. PubMed ID: 26886386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of portal hypertension with transjugular intrahepatic portosystemic shunt: guidelines for referring suitable patients].
    Astrup LB; Clemmesen JO; Frevert SC; Larsen FS; Nielsen DT; Schlichting P; Vilstrup H
    Ugeskr Laeger; 2007 Aug; 169(34):2758-61. PubMed ID: 17878010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of refractory ascites using a transjugular intrahepatic portosystemic shunt (TIPS). Clinical case].
    Zapata R; Fava M
    Rev Med Chil; 1999 Oct; 127(10):1229-35. PubMed ID: 10835740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.